$1.35 Billion in Sales Expected for Encompass Health Co. (NYSE:EHC) This Quarter

Wall Street brokerages expect Encompass Health Co. (NYSE:EHCGet Rating) to report sales of $1.35 billion for the current quarter, according to Zacks. Five analysts have made estimates for Encompass Health’s earnings, with estimates ranging from $1.33 billion to $1.37 billion. Encompass Health posted sales of $1.29 billion in the same quarter last year, which would indicate a positive year-over-year growth rate of 4.7%. The firm is scheduled to issue its next quarterly earnings report on Monday, January 1st.

According to Zacks, analysts expect that Encompass Health will report full year sales of $5.43 billion for the current year, with estimates ranging from $5.32 billion to $5.46 billion. For the next year, analysts forecast that the firm will report sales of $5.88 billion, with estimates ranging from $5.72 billion to $5.97 billion. Zacks Investment Research’s sales calculations are a mean average based on a survey of research firms that that provide coverage for Encompass Health.

Encompass Health (NYSE:EHCGet Rating) last issued its earnings results on Wednesday, April 27th. The company reported $0.97 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.93 by $0.04. The company had revenue of $1.33 billion during the quarter, compared to the consensus estimate of $1.32 billion. Encompass Health had a return on equity of 19.20% and a net margin of 8.05%. The firm’s revenue for the quarter was up 8.4% compared to the same quarter last year. During the same period last year, the business posted $1.05 EPS.

A number of brokerages have recently weighed in on EHC. Zacks Investment Research upgraded Encompass Health from a “sell” rating to a “hold” rating and set a $76.00 target price on the stock in a research note on Monday, April 11th. Truist Financial boosted their target price on Encompass Health from $78.00 to $85.00 in a research note on Thursday, April 7th. StockNews.com began coverage on Encompass Health in a research note on Thursday, March 31st. They issued a “hold” rating on the stock. Credit Suisse Group cut their target price on Encompass Health from $84.00 to $77.00 in a research note on Thursday, February 3rd. Finally, TheStreet upgraded Encompass Health from a “c+” rating to a “b-” rating in a research note on Tuesday, March 15th. Two equities research analysts have rated the stock with a hold rating, seven have assigned a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Buy” and a consensus target price of $83.89.

EHC stock opened at $68.36 on Friday. The company has a market capitalization of $6.80 billion, a P/E ratio of 16.63, a price-to-earnings-growth ratio of 2.49 and a beta of 0.99. The company has a debt-to-equity ratio of 1.38, a quick ratio of 1.23 and a current ratio of 1.23. Encompass Health has a 52-week low of $56.31 and a 52-week high of $88.58. The business has a 50-day simple moving average of $69.25 and a two-hundred day simple moving average of $65.96.

The firm also recently announced a quarterly dividend, which was paid on Monday, April 18th. Shareholders of record on Friday, April 1st were issued a dividend of $0.28 per share. The ex-dividend date was Thursday, March 31st. This represents a $1.12 dividend on an annualized basis and a yield of 1.64%. Encompass Health’s payout ratio is 27.25%.

A number of hedge funds have recently modified their holdings of the business. BlackRock Inc. raised its holdings in Encompass Health by 1.4% during the 4th quarter. BlackRock Inc. now owns 10,643,463 shares of the company’s stock valued at $694,594,000 after acquiring an additional 145,130 shares during the period. Wellington Management Group LLP grew its position in shares of Encompass Health by 5.8% during the 3rd quarter. Wellington Management Group LLP now owns 8,181,371 shares of the company’s stock valued at $613,929,000 after purchasing an additional 450,688 shares in the last quarter. State Street Corp grew its position in shares of Encompass Health by 1.2% during the 4th quarter. State Street Corp now owns 2,602,750 shares of the company’s stock valued at $170,580,000 after purchasing an additional 29,795 shares in the last quarter. TimesSquare Capital Management LLC grew its position in shares of Encompass Health by 0.8% during the 3rd quarter. TimesSquare Capital Management LLC now owns 1,408,245 shares of the company’s stock valued at $105,675,000 after purchasing an additional 11,425 shares in the last quarter. Finally, Invesco Ltd. grew its position in shares of Encompass Health by 14.0% during the 4th quarter. Invesco Ltd. now owns 1,389,517 shares of the company’s stock valued at $90,679,000 after purchasing an additional 170,155 shares in the last quarter. 92.35% of the stock is currently owned by institutional investors and hedge funds.

About Encompass Health (Get Rating)

Encompass Health Corporation provides facility-based and home-based post-acute healthcare services in the United States. The company operates in two segments, Inpatient Rehabilitation, and Home Health and Hospice. The Inpatient Rehabilitation segment provides specialized rehabilitative treatment on an inpatient and outpatient basis to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations.

Further Reading

Get a free copy of the Zacks research report on Encompass Health (EHC)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Encompass Health (NYSE:EHC)

Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.